Literature DB >> 23541936

Use of archived biopsy specimens to study gene expression in oral mucosa from chemotherapy-treated cancer patients.

Jean-Luc C Mougeot1, Farah K B Mougeot, Douglas E Peterson, Ricardo J Padilla, Michael T Brennan, Peter B Lockhart.   

Abstract

OBJECTIVES: Oral mucositis caused by cancer chemotherapy can result in significant clinical complications. There is a strategic need to accelerate the delineation of the pathobiology. This proof-of-principle study was designed to demonstrate the feasibility of studying archived oral mucosal specimens to further delineate oral mucositis pathobiology.
MATERIALS AND METHODS: Twenty-nine formalin-fixed and paraffin-embedded tissue blocks of 25-year-old oral mucosa autopsy specimens from cancer chemotherapy patients were studied. Standardized technology was utilized, including RNA isolation and amplification, array hybridization, and gene expression analysis.
RESULTS: A predominance of DNA damage in buccal mucosal basal keratinocytes was observed. Data comparing basal cells from buccal vs. gingival mucosa identified differential gene expression of host responses in relation to pathways relevant to oral mucositis pathogenesis, including responses to cancer-associated inflammation.
CONCLUSIONS: This proof-of-principle study demonstrated that archived oral mucosal specimens may be a potentially valuable resource for the study of oral mucositis in cancer patients.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541936     DOI: 10.1016/j.oooo.2013.01.003

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  2 in total

1.  Comprehensive Assessment of Host Responses to 5-Fluorouracil-Induced Oral Mucositis through Transcriptomic Analysis.

Authors:  Chung-Ta Chang; Chien-Yun Hsiang; Tin-Yun Ho; Ching-Zong Wu; Hsiang-Hsi Hong; Yi-Fang Huang
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

Review 2.  Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.

Authors:  Douglas E Peterson; Joyce A O'Shaughnessy; Hope S Rugo; Sharon Elad; Mark M Schubert; Chi T Viet; Cynthia Campbell-Baird; Jan Hronek; Virginia Seery; Josephine Divers; John Glaspy; Brian L Schmidt; Timothy F Meiller
Journal:  Cancer Med       Date:  2016-06-23       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.